Published • loading... • Updated
The Hidden Cost of GLP-1s: Popularity Surge Raises Long-Term Affordability Questions
A recent ICER report says the drugs deliver strong health value, but insurers still face budget pressures and many patients stop treatment within a year.
- A report from the Institute for Clinical and Economic Review found GLP-1 medications are cost-effective, yet many insurance plans still limit coverage despite evidence of health benefits.
- GLP-1 usage among adults without diabetes surged 643% over five years, driving costs past the $821 million budget impact threshold established by ICER for this year.
- Sujith Ramachandran, associate professor of pharmacy administration, noted that "cost-effective" does not necessarily mean "cost-saving" for insurance companies given the massive eligible patient population.
- Xiaoning Huang, assistant professor of medicine at Northwestern University Feinberg School of Medicine, warned that insurers pass higher drug spending to consumers through increased premiums and deductibles.
- Healthcare providers must combine GLP-1 medications with lifestyle management—including dietitian access, gym memberships and fitness support—to ensure long-term benefits as coverage becomes more restrictive for many conditions.
Insights by Ground AI
16 Articles
16 Articles
High costs continue limiting insurance coverage for GLP-1 medications
Despite growing evidence that GLP-1 medications improve health and are worth their cost, many insurance plans still limit coverage. University of Mississippi researchers are examining why, and where that leaves patients.
·Mona Vale, Australia
Read Full Article
People Want GLP-1s. Will Employers Adapt?
What started as a breakthrough treatment for Type 2 diabetes has evolved into a phenomena reshaping employer health benefits, pharmacy operations, and insurance plans. GLP-1 drugs are more popular than ever. Today, 11% of U.S. adults currently take GLP-1 (glucagon-like peptide-1) medications for weight loss, up significantly from 3% in 2024, according to a survey from Gallup, a global analytics and advisory firm. Further, 15% report having used …
Coverage Details
Total News Sources16
Leaning Left0Leaning Right0Center15Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
